Aviva’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,320
Closed -$428K 983
2023
Q2
$428K Buy
+6,320
New +$396K ﹤0.01% 897
2018
Q4
Sell
-53,699
Closed -$3.33M 753
2018
Q3
$3.33M Hold
53,699
0.02% 621
2018
Q2
$2.89M Hold
53,699
0.02% 636
2018
Q1
$2.44M Sell
53,699
-1,194
-2% -$51.2K 0.01% 654
2017
Q4
$2.16M Hold
54,893
0.01% 665
2017
Q3
$2.02M Hold
54,893
0.01% 678
2017
Q2
$2.13M Buy
54,893
+22,123
+68% +$810K 0.01% 693
2017
Q1
$1.12M Hold
32,770
0.01% 722
2016
Q4
$1.07M Hold
32,770
0.01% 712
2016
Q3
$1.06M Buy
+32,770
New +$1.06M 0.01% 733

Other funds holding EHC

Aviva's EHC Position: Q3 2023 in Review

Aviva sold out of Encompass Health (EHC) in Q3 2023, closing a stake of 6,320 shares — an estimated $428K sold.

Aviva first reported a position in EHC in Q3 2016 and held it in 10 quarters. The position peaked at $3.33M in Q3 2018. 412 funds tracked by Wall St. Rank hold EHC as of Q3 2023.

  • Aviva reported no remaining Encompass Health position as of Q3 2023 after selling out during the quarter.
  • Aviva sold 6,320 Encompass Health shares in Q3 2023, an estimated $428K.
  • Aviva first reported a position in Encompass Health in Q3 2016 and held it in 10 quarters.
  • Aviva's Encompass Health position peaked at $3.33M in Q3 2018.
  • 412 funds tracked by Wall St. Rank held Encompass Health as of Q3 2023.

Based on Aviva's 13F filing for Q3 2023, filed 13 Nov 2023.